These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 23101625)

  • 1. Activation of innate immunity is required for efficient nuclear reprogramming.
    Lee J; Sayed N; Hunter A; Au KF; Wong WH; Mocarski ES; Pera RR; Yakubov E; Cooke JP
    Cell; 2012 Oct; 151(3):547-58. PubMed ID: 23101625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic Acid Inducible Gene 1 Protein (RIG1)-Like Receptor Pathway Is Required for Efficient Nuclear Reprogramming.
    Sayed N; Ospino F; Himmati F; Lee J; Chanda P; Mocarski ES; Cooke JP
    Stem Cells; 2017 May; 35(5):1197-1207. PubMed ID: 28276156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
    Liu C; Ameen M; Himmati S; Thomas D; Sayed N
    Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionality and transduction condition evaluation of recombinant Klf4 for improved reprogramming of iPS cells.
    Tang Y; Lin CJ; Tian XC
    Cell Reprogram; 2011 Apr; 13(2):99-112. PubMed ID: 21473687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
    Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
    Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear
    Chanda PK; Meng S; Lee J; Leung HE; Chen K; Cooke JP
    Circulation; 2019 Sep; 140(13):1081-1099. PubMed ID: 31412725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal ROS Signaling Is Critical for Nuclear Reprogramming.
    Zhou G; Meng S; Li Y; Ghebre YT; Cooke JP
    Cell Rep; 2016 May; 15(5):919-925. PubMed ID: 27117405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency.
    Liu P; Chen M; Liu Y; Qi LS; Ding S
    Cell Stem Cell; 2018 Feb; 22(2):252-261.e4. PubMed ID: 29358044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
    Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
    Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.
    Fritz AL; Adil MM; Mao SR; Schaffer DV
    Mol Ther; 2015 May; 23(5):952-963. PubMed ID: 25666918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
    Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
    Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
    An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
    Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient genetic reprogramming of unmodified somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4.
    Di Stefano B; Prigione A; Broccoli V
    Stem Cells Dev; 2009 Jun; 18(5):707-16. PubMed ID: 18724799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
    Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
    Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
    Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
    Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
    Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
    BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transflammation: Innate immune signaling in nuclear reprogramming.
    Meng S; Chanda P; Thandavarayan RA; Cooke JP
    Adv Drug Deliv Rev; 2017 Oct; 120():133-141. PubMed ID: 28916494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.